abstract |
The present invention relates to the field of immunology. More particularly, it relates to the field of immune-mediated diseases such as allergies, autoimmune diseases, diseases related to transplantation and inflammatory diseases. The present invention provides immunomodulators (NMPF), the preparation of pharmaceutical ingredients for the treatment of immune-mediated diseases, the use of pharmaceutical ingredients, and the use of NMPF in methods for treating immune-mediated diseases. |